CPT 0539T
Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
Chimeric antigen receptor T-cell (CAR-T) therapy; receipt and preparation of CAR-T cells for administration
Low
$1.4k
Average
$5.6k
Median
$5.6k
High
$9.9k
Filter by billing methodology
Filter by billing class
3 hospital rates
iThe hospitals that file a Highmark rate for this code, one row per hospital and set of terms (billing class, payment method, setting). Rates under different terms are never blended, so the terms are shown under each hospital’s name. Figures are the hospital’s averages across its plans.| # | Plans | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Lancaster General Health Lancaster, PA facility · other · outpatient | 5 | $7.7k | $8.3k | $2.1k | 26% | — | $5.6k – $11.7k |
| 2 | Lancaster General Health Lancaster, PA facility · percent of total billed charges · inpatientfrom % of charges | 5 | $11.6k | $11.6k | — | — | — | $11.6k – $11.6k |
| 3 | UPMC Magee-Womens Hospital Pittsburgh, PA facility · percent of total billed charges · outpatientfrom % of charges | 6 | $1.3k | $1.4k | $332 | 25% | — | $871 – $2.0k |
← Payers reporting CPT 0539T · Snapshot 20261113T090226Z-3ce6c0b8